As the opioid epidemic grows increasingly more dangerous, the ability of patients to fulfill their prescriptions for naloxone, an opioid antagonist that can reverse overdose, has never been more important. However, a new U-M study shows patients are less likely to fill prescriptions for naloxone when they face out-of-pocket costs. In this article from the Institute for Healthcare Policy and Innovation, study lead author and professor from the U-M Medical School and School of Public Health, Kao-Ping Chua, Ph.D., M.D., comments on the study’s findings.
